GSAGE Trademark

Trademark Overview


On Thursday, October 10, 2024, a trademark application was filed for GSAGE with the United States Patent and Trademark Office. The USPTO has given the GSAGE trademark a serial number of 98795264. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 16, 2025. This trademark is owned by GeneSilico Inc.. The GSAGE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing online non-downloadable computer software platform for using generative artificial intelligence (AI) to provide clinical decision support in the fields of genomics and cancer research, testing, diagnosis and treatment; Software as a Service (SAAS) services featuring software using generative artificial intelligence (AI) to provide clinical decision support in the fields of genomics and cancer research, testing, diagnosis and treatment; Software as a Service (SAAS) services featuring software for genetic testing for medical purposes; Software as a Service (SAAS) services featuring genetic testing panels, generative artificial intelligence (AI) insights for oncology related clinical decision support, precision oncologist and patient services
gsage

General Information


Serial Number98795264
Word MarkGSAGE
Filing DateThursday, October 10, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, September 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 16, 2025

Trademark Statements


Pseudo MarkGENE SAGE
Goods and ServicesProviding online non-downloadable computer software platform for using generative artificial intelligence (AI) to provide clinical decision support in the fields of genomics and cancer research, testing, diagnosis and treatment; Software as a Service (SAAS) services featuring software using generative artificial intelligence (AI) to provide clinical decision support in the fields of genomics and cancer research, testing, diagnosis and treatment; Software as a Service (SAAS) services featuring software for genetic testing for medical purposes; Software as a Service (SAAS) services featuring genetic testing panels, generative artificial intelligence (AI) insights for oncology related clinical decision support, precision oncologist and patient services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 10, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGeneSilico Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAustin, TX 78746

Party NameGeneSilico Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAustin, TX 78746

Trademark Events


Event DateEvent Description
Thursday, October 10, 2024NEW APPLICATION ENTERED
Tuesday, April 15, 2025ASSIGNED TO EXAMINER
Monday, April 14, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 21, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 21, 2025NON-FINAL ACTION WRITTEN
Monday, April 21, 2025NON-FINAL ACTION E-MAILED
Friday, July 18, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 18, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 18, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 10, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 16, 2025PUBLISHED FOR OPPOSITION
Tuesday, September 16, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, August 13, 2025APPROVED FOR PUB - PRINCIPAL REGISTER